HighTower Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,208
Closed -$16K 3891
2023
Q3
$16K Buy
+10,208
New +$28.2K ﹤0.01% 3348

Other funds holding RNLX

HighTower Advisors's RNLX Position: Q4 2023 in Review

HighTower Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 10,208 shares — an estimated $16K sold.

HighTower Advisors first reported a position in RNLX in Q3 2023 and held it in 1 quarter. The position peaked at $16K in Q3 2023. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • HighTower Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • HighTower Advisors sold 10,208 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $16K.
  • HighTower Advisors first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 1 quarter.
  • HighTower Advisors's Renalytix plc American Depositary Shares position peaked at $16K in Q3 2023.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.